A New York-based biotech firm announced it has raised an additional $200 million in financing to advance commercialization of ...

Researchers in Shanghai have reported in a study, recently published in Science Advances, that they've successfully decoded ...

The partners aim to develop AI-powered, real-time, personalized brain-computer interface therapies for neurological disorders ...

Inbrain Neuroelectronics signed a pact with Microsoft to use the tech giant’s Azure AI infrastructure to advance the Spanish ...

The company will use the money to accelerate pivotal trials and prepare for commercial launch of the Stentrode BCI system.

The company will use the funds to expand its in-house operations in New York and San Diego, as well as accelerate the trials ...

Researchers propose a novel closed-loop system merging brain-computer interfaces and peripheral nerve stimulation to enable ...

Cognixion’s Vision Pro study shows how Apple’s accessibility framework is shaping the future of healthcare and communication ...

Synchron Funding will advance commercialization of the Stentrode™ BCI platform and expand AI and engineering operations in New York and San Diego The round was led by Double Point Ventures, alongside ...

Courtesy of Nanjing Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University. The first intelligent clinical research ward dedicated to brain-computer interface ...

Australia has invested $54 million in Melbourne-born brain-computer interface company Synchron, the federal government’s ...

INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, today announced a strategic collaboration with Microsoft to explore ...